Bruker has announced the planned discontinuation of the IsoSpark and IsoLight platforms. Customers with questions about transition options and last-time-buy opportunities should contact their Bruker sales representative.

Row rect Shape Decorative svg added to bottom
Back to Webinars
Biomarker Strategies for Optimizing Checkpoint Immunotherapy Treatment

Featured Speakers: Naval Daver, PhD, Associate Professor, Department of Leukemia, MD Anderson Cancer Center

What's Inside

In this Webinar we discuss:

Review advanced immune-based approaches in acute myeloid leukemia that combine chemotherapy with checkpoint therapy

Explore relevant biomarker strategies associated with these approaches

See how single-cell cytokine analysis system and PSI demonstrate that specific cytokine potency contributors correlate with overall survival

awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Row rect Shape Decorative svg added to top
Watch the Webinar
Back to the Top